Will INJ and AAVE Navigate Market Volatility to Emerge as Top Performers?
INJ sees a slight uptick, now at $34.61, hinting at a bullish reversal amidst $254M trading activity. Injective Protocol’s gas-free cross-chain trading fuels popularity, with market cap soaring over $3.2B. AAVE eyes the $100 mark after a 0.44% increase, signaling substantial accumulation and potential breakout. The bearish channel formation of the Injective Protocol (INJ) has...